Medifast ( NYSE:MED ) First Quarter 2024 Results Key Financial Results Revenue: US$174.7m (down 50% from 1Q 2023). Net...
Medifast's (MED) first-quarter results reflect challenges related to a decline in active earning OPTAVIA Coaches, lower coach productivity and soft sales volume.
Shares of wellness company Medifast (NYSE:MED) fell 26.8% in the morning session after the company reported first quarter results that narrowly topped analysts' revenue expectations. However, revenue declined 49% in absolute terms, primarily driven by a decline in active earning OPTAVIA Coaches as well as lower Coach productivity. The company also called out a $9.1 million headwind due to timing differences from changes to sales order terms. Looking ahead, guidance was weak. The company's revenu